Decitabine (Decitabine) Lyophilized Powder


Indications and Reactions:

Role Indications Reactions
Primary
Myelodysplastic Syndrome 43.4%
Acute Myeloid Leukaemia 37.4%
Drug Use For Unknown Indication 3.8%
Myeloid Leukaemia 3.3%
Product Used For Unknown Indication 2.3%
Ovarian Cancer 1.9%
Chronic Myelomonocytic Leukaemia 1.3%
Neoplasm 1.2%
Acute Myeloid Leukaemia Recurrent 1.0%
Metastatic Malignant Melanoma 0.8%
Infection Prophylaxis 0.6%
Pneumonia Fungal 0.6%
Colorectal Cancer 0.4%
Electrocardiogram Qt Prolonged 0.4%
Myelofibrosis 0.4%
Serum Ferritin Increased 0.4%
Thrombocytopenia 0.4%
Antibiotic Therapy 0.2%
Anxiety 0.2%
Chronic Myeloid Leukaemia 0.2%
White Blood Cell Count Decreased 21.3%
Thrombocytopenia 20.3%
Vomiting 8.7%
Pyrexia 4.3%
Septic Shock 4.3%
Pneumonia 3.9%
Syncope 3.9%
Urinary Tract Infection 3.9%
Vasculitis 3.9%
Sepsis 3.4%
Staphylococcal Infection 3.4%
Platelet Count Decreased 2.9%
Pancytopenia 2.4%
Parotitis 2.4%
Loss Of Consciousness 1.9%
Renal Failure Acute 1.9%
Right Ventricular Systolic Pressure Increased 1.9%
Tonsillitis 1.9%
Vision Blurred 1.9%
Appendicitis 1.4%
Secondary
Myelodysplastic Syndrome 92.0%
Product Used For Unknown Indication 8.0%
Vision Blurred 38.9%
Loss Of Consciousness 16.7%
Thrombocytopenia 11.1%
Anaemia 5.6%
Disease Progression 5.6%
General Physical Health Deterioration 5.6%
Neutropenic Colitis 5.6%
Oedema Peripheral 5.6%
Pyrexia 5.6%

Drug Data